Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

The future of epilepsy treatment: focus on adeno-associated virus vector gene therapy.

McCown TJ.

Drug News Perspect. 2010 Jun;23(5):281-6. doi: 10.1358/dnp.2010.23.5.1468393. Review.

PMID:
20603651
3.

The state of the art of adeno-associated virus-based vectors in gene therapy.

Coura Rdos S, Nardi NB.

Virol J. 2007 Oct 16;4:99. Review. Erratum in: Virol J. 2010;7:12.

4.

Clinical gene therapy using recombinant adeno-associated virus vectors.

Mueller C, Flotte TR.

Gene Ther. 2008 Jun;15(11):858-63. doi: 10.1038/gt.2008.68. Epub 2008 Apr 17. Review.

PMID:
18418415
5.

The role of the adeno-associated virus capsid in gene transfer.

Van Vliet KM, Blouin V, Brument N, Agbandje-McKenna M, Snyder RO.

Methods Mol Biol. 2008;437:51-91. doi: 10.1007/978-1-59745-210-6_2. Review.

PMID:
18369962
6.

Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.

Fraefel C, Jacoby DR, Lage C, Hilderbrand H, Chou JY, Alt FW, Breakefield XO, Majzoub JA.

Mol Med. 1997 Dec;3(12):813-25.

7.
8.

Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.

Yang L, Li J, Xiao X.

Methods Mol Biol. 2011;709:127-39. doi: 10.1007/978-1-61737-982-6_8.

PMID:
21194025
9.

Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.

High KA.

Trans Am Clin Climatol Assoc. 2003;114:337-51; discussion 351-2. Review.

10.

Adeno-associated virus vector mediated gene transfer to pancreatic beta cells.

Prasad KM, Yang Z, Bleich D, Nadler JL.

Gene Ther. 2000 Sep;7(18):1553-61.

11.

Cancer gene therapy using adeno-associated virus vectors.

Park K, Kim WJ, Cho YH, Lee YI, Lee H, Jeong S, Cho ES, Chang SI, Moon SK, Kang BS, Kim YJ, Cho SH.

Front Biosci. 2008 Jan 1;13:2653-9. Review.

PMID:
17981740
12.
13.

Direct gene transfer into human epileptogenic hippocampal tissue with an adeno-associated virus vector: implications for a gene therapy approach to epilepsy.

Freese A, Kaplitt MG, O'Connor WM, Abbey M, Langer D, Leone P, O'Connor MJ, During MJ.

Epilepsia. 1997 Jul;38(7):759-66.

14.

Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.

Li Q, Miller R, Han PY, Pang J, Dinculescu A, Chiodo V, Hauswirth WW.

Mol Vis. 2008 Sep 24;14:1760-9.

15.

Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency.

Hacker UT, Wingenfeld L, Kofler DM, Schuhmann NK, Lutz S, Herold T, King SB, Gerner FM, Perabo L, Rabinowitz J, McCarty DM, Samulski RJ, Hallek M, B√ľning H.

J Gene Med. 2005 Nov;7(11):1429-38.

PMID:
15945124
16.

AAV-mediated gene transfer for hemophilia.

High KA.

Ann N Y Acad Sci. 2001 Dec;953:64-74. Review.

PMID:
11795424
17.

Current development of adeno-associated viral vectors.

Romano G.

Drug News Perspect. 2005 Jun;18(5):311-6. Review.

PMID:
16193103
18.

Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.

Conrad CK, Allen SS, Afione SA, Reynolds TC, Beck SE, Fee-Maki M, Barrazza-Ortiz X, Adams R, Askin FB, Carter BJ, Guggino WB, Flotte TR.

Gene Ther. 1996 Aug;3(8):658-68.

PMID:
8854091
19.

Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity.

McCown TJ.

Neurotherapeutics. 2009 Apr;6(2):307-11. doi: 10.1016/j.nurt.2009.01.004. Review.

20.

Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus.

Richichi C, Lin EJ, Stefanin D, Colella D, Ravizza T, Grignaschi G, Veglianese P, Sperk G, During MJ, Vezzani A.

J Neurosci. 2004 Mar 24;24(12):3051-9.

Items per page

Supplemental Content

Write to the Help Desk